Magazine | IBA | Protect Enhance and Save lives

Improving the proton therapy journey of cancer centers

When a cancer center decides to add proton therapy to its radiation oncology department, it makes a long-term commitment to therapeutic innovation and high-quality patient care. A question remains essential: how to select the best proton therapy equipment provider, to ensure optimal installation and best-in-class performance throughout the system’s lifecycle?

Does IBA support radiation oncology centers in improving their proton therapy journey?

Shreveport’s Community Hospital opts for Proton Therapy

Dr. Lane Rosen, Director of Radiation Oncology at Willis Knighton Cancer Center in Shreveport, Louisiana, highlights the transformative impact of introducing proton therapy with the ProteusONE system at their facility. In this blog, he shares insights into how a community hospital can successfully implement proton therapy, traditionally reserved for larger academic centers.

The Strategic and Clinical Benefits of Compact Proton Therapy at TMUH

In the heart of Taipei, where every square meter is precious and the demand for advanced healthcare is ever-growing, Taipei Medical University Hospital (TMUH) redefined its approach to cancer care by integrating proton therapy as a core component of its world-class oncology program. At the core of this transformation is ProteusONE, IBA’s compact proton therapy system, selected for its ability to address the unique challenges of urban hospital environments while meeting TMUH’s clinical needs for precision and efficiency.

In this article, we dive into the expert testimonials of five TMUH leaders whose roles span the entire proton therapy ecosystem: from institutional leadership to hands-on patient care. Their combined insights reveal how ProteusONE has overcome spatial and operational constraints, redefined clinical efficiency, enhanced the patient experience, and strengthened TMUH’s institutional strategy in one of Asia’s most densely populated cities.

The role of proton beam quality in cancer treatment

In proton therapy, the design of the system significantly influences key beam parameters, and can have a direct impact on patient care. Thus, it is important to understand beam quality's role in radiotherapy and cancer treatment.

Overcome staff shortages and improve patient experience in radiation oncology clinics

As a hospital executive, head of the radiotherapy department, radiation oncologist, medical physicist or radiotherapist, you may wonder if adding proton therapy treatment to your radiation oncology department can increase your hospital’s attractivity, improve cancer patient experience, and contribute to talent attraction and retention.

Proton Therapy and the Future of Precision Cancer Care: insights from ESTRO’s President-Elect

Prof. Barbara Alicja Jereczek-Fossa is Chair of Radiation Oncology at the European Institute of Oncology (IEO) in Milan and full Professor at the University of Milan, in Italy. She was elected President of the European Society for Radiotherapy and Oncology (ESTRO) in 2024 and her term is set to begin in 2026. ESTRO’s mission is to reinforce radiation oncology as a core partner in multidisciplinary cancer care and to guarantee accessible and high-value radiation therapy for all cancer patients who need it. Prof. Jereczek-Fossa, a highly respected radiation oncologist, brings decades of clinical experience, institutional leadership at the IEO, and a powerful vision for expanding access to precision therapies like proton therapy worldwide. This article highlights her view on proton therapy and the future of precision cancer care.

Compact Proton Therapy at IEO Milan: Precision, Comfort, and Future-Ready Care

Find out how ProteusONE at IEO Milan combines precision, patient comfort, and future-ready technology to set new standards in cancer care.

Cookies policy

Manage your cookie preferences